Breaking News
Investing Pro 0
Free Webinar - Master Forex Trading Today! Don't Miss Out | Tuesday, June 6, 2023 | 01:00PM EDT Enroll Now

Biden administration vaccine drive leader David Kessler to step down

Published Jan 13, 2023 03:37PM ET Updated Jan 13, 2023 07:56PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO: Former Food and Drug Administration Commissioner David Kessler (C) speaks to the press after presenting the White House with an alternative approach charted by leading U. S. public health groups that would be tougher on the cigarette industry.

(Reuters) - David Kessler, who led the COVID-19 vaccine distribution efforts for the United States, is stepping down from President Joe Biden's administration, the Department of Health and Human Services confirmed on Friday.

Kessler, a pediatrician and lawyer who headed the U.S. Food and Drug Administration under presidents George H.W. Bush and Bill Clinton, will return to teaching at the University of California, San Francisco, the New York Times reported earlier.

Kessler could not be immediately reached for comment.

The 71-year-old's departure reflects the changing strategy of the Biden administration to shift COVID-19 vaccines to the commercial market from a government-run effort. The former FDA commissioner was chosen to help lead the U.S. COVID-19 vaccine program Operation Warp Speed in January 2021.

As head of the FDA, Kessler cut the time needed to approve drugs to treat AIDS and moved to try to regulate the tobacco industry. He also served as a co-chair of Biden's advisory board on the pandemic.

Biden administration vaccine drive leader David Kessler to step down
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (2)
Al Zuni
Al Zuni Jan 17, 2023 2:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it's not a vaccine
William Smith
William Smith Jan 13, 2023 5:14PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Another failure as vaccines continue to not only be shunned in mass but there safety are being questioned more snd more as evidence mounts of dangerous health concerms.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email